Anuh Pharma Ltd. - Research Center
506260 ANUHPHR Group (X) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
25.06 |
25.06 |
25.06 |
12.53 |
12.53 |
Share application money
Preference share capital
Reserves & surplus
216.17 |
188.72 |
165.59 |
149.68 |
152.07 |
Secured loans
Unsecured loans
Total
241.22 |
216.88 |
204.24 |
206.77 |
168.99 |
Gross block
99.53 |
98.57 |
97.17 |
96.17 |
26.36 |
Less : revaluation reserve
Less : accumulated depreciation
46.72 |
37.15 |
25.75 |
12.13 |
5.19 |
Net block
52.81 |
61.42 |
71.42 |
84.04 |
21.17 |
Capital work-in-progress
Investments
90.83 |
42.68 |
31.39 |
79.56 |
38.65 |
Current assets, loans & advances
261.34 |
242.97 |
229.83 |
162.77 |
146.59 |
Less : current liabilities & provisions
163.76 |
130.29 |
128.40 |
119.61 |
71.28 |
Total net current assets
97.58 |
112.68 |
101.43 |
43.17 |
75.31 |
Miscellaneous expenses not written
Total
241.22 |
216.88 |
204.24 |
206.77 |
168.99 |
Book value of unquoted investments
89.03 |
40.87 |
29.58 |
77.75 |
36.85 |
Market value of quoted investments
Contingent liabilities
30.33 |
32.92 |
23.39 |
33.07 |
26.04 |
Number of equity sharesoutstanding (Lacs)
501.12 |
501.12 |
501.12 |
250.56 |
250.56 |